Pretax income is the income that a company earns before paying income taxes. Solid Biosciences's pretax income for the
three
months ended in Mar. 2024 was $-24.30 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-90.25 Mil.
Solid Biosciences's pretax margin was %.
During the past 9 years, Solid Biosciences's highest Pretax Margin was -530.01%. The lowest was -1062.28%. And the median was -796.15%.
Solid Biosciences Pre-Tax Income Historical Data
The historical data trend for Solid Biosciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Solid Biosciences's Pre-Tax Income
For the Biotechnology subindustry, Solid Biosciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solid Biosciences's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Solid Biosciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Solid Biosciences's Pre-Tax Income falls into.
Solid Biosciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Solid Biosciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-90.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solid Biosciences (NAS:SLDB) Pre-Tax Income Explanation
Solid Biosciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 9 years, Solid Biosciences's highest Pretax Margin was -530.01%. The lowest was -1062.28%. And the median was -796.15%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solid Biosciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Solid Biosciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Solid Biosciences (Solid Biosciences) Business Description
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SLDB has been successfully added to your 